you are here: Home News Pharma Companies

Pharma Companies

Bangladesh political turmoil affects India’s pharma exports, medical tourism: Report
NMC puts on hold its regulations mandating doctors to prescribe generic drugs, bar them from endorsing any drug brand
Mandaviya bats for self-regulation by small pharma firms, says won’t compromise on drug quality
Pharma companies take FDC drugs off shelves after central govt ban
As govt readies plans to test drugs before export, industry stresses on quality management
Got Rs 10 lakh to invest? Tata MF’s fund manager picks 3 mutual funds to ride out volatile markets
Growth drivers are finally falling in place for large pharma companies
'Freebies' to doctors: Pharma industry lobby seeks new code to regulate marketing interaction
Govt Forms Panel to Review Marketing Practices of Pharma Firms, Sets 90-day Cut-off for Report
Mansukh Mandaviya asks pharma industry to tackle spurious drug menace
Rise in essential drug prices may not boost pharma earnings significantly
Pharma companies turn to acquisitions to build scale, gain an edge
India remains a bright spot for pharma companies
Coronavirus impact| Pharma companies to see earnings growth: Aditya Khemka, DSP MF
Indian pharma sector's growth slips to 7.6% in January, anti-diabetes segment a drag
Reporter's Take | More problems for Lupin as USFDA cautions company
Reporter's Take | How safe are generic drugs?
Proposed cap on trade margins will not hurt pharma cos: Fitch
Reporter's Take | India's job market looks strong in 2019
Indian pharma cos should partner Chinese manufacturers for greater market access: Study
How the US regulator's import ban has pushed Divis off its pedestal
CEOs of pharma cos to discuss key challenges within industry
Scrapping Obamacare would hit most pharma cos: Jeff Chowdhry
e-Pharmacy to Provide Growth Opportunities for Pharma Companies and Last Mile Access of Medicines to Patients, Finds Frost & Sullivan
IPA files contempt petition against NPPA

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Pharma Companies

Bangladesh political turmoil affects India’s pharma exports, medical tourism: Report

NMC puts on hold its regulations mandating doctors to prescribe generic drugs, bar them from endorsing any drug brand

Mandaviya bats for self-regulation by small pharma firms, says won’t compromise on drug quality

Pharma companies take FDC drugs off shelves after central govt ban

As govt readies plans to test drugs before export, industry stresses on quality management

Got Rs 10 lakh to invest? Tata MF’s fund manager picks 3 mutual funds to ride out volatile markets

Growth drivers are finally falling in place for large pharma companies

'Freebies' to doctors: Pharma industry lobby seeks new code to regulate marketing interaction

Govt Forms Panel to Review Marketing Practices of Pharma Firms, Sets 90-day Cut-off for Report

Mansukh Mandaviya asks pharma industry to tackle spurious drug menace

Rise in essential drug prices may not boost pharma earnings significantly

Pharma companies turn to acquisitions to build scale, gain an edge

India remains a bright spot for pharma companies

Coronavirus impact| Pharma companies to see earnings growth: Aditya Khemka, DSP MF

Indian pharma sector's growth slips to 7.6% in January, anti-diabetes segment a drag

Reporter's Take | More problems for Lupin as USFDA cautions company

Reporter's Take | How safe are generic drugs?

Proposed cap on trade margins will not hurt pharma cos: Fitch

Reporter's Take | India's job market looks strong in 2019

Indian pharma cos should partner Chinese manufacturers for greater market access: Study

How the US regulator's import ban has pushed Divis off its pedestal

CEOs of pharma cos to discuss key challenges within industry

Scrapping Obamacare would hit most pharma cos: Jeff Chowdhry

e-Pharmacy to Provide Growth Opportunities for Pharma Companies and Last Mile Access of Medicines to Patients, Finds Frost & Sullivan

IPA files contempt petition against NPPA